Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan

Circulation Journal

Volumn 76, Issue 5, 2012, Pages 1066-1073

  Saito, Isao ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Epidemiology; Japan; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; GLUCOSE INTOLERANCE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; JAPAN; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; RISK FACTOR; STROKE; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BODY MASS INDEX; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84860208900     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1519     Document Type: Article

References (81)

1. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222.
2. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of causespecific death. N Engl J Med 2011; 364: 829-841.
3. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: Insights from mechanistic studies. Lancet 2008; 371: 1800-1809.
4. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605.
5. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links: The Claude Bernard Lecture 2009. Diabetologia 2010; 53: 1270-1287.
6. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581.
7. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
8. Kawamori R. Diabetes trends in Japan. Diabetes Metab Res Rev 2002; 18(Suppl 3): S9-S13.
9. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: The Akita-Osaka study. J Am Coll Cardiol 2008; 52: 71-79.
10. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008; 118: 2725-2729.
11. Konishi M, Iso H, Iida M, Naito Y, Sato S, Komachi Y, et al. Trends for coronary heart disease and its risk factors in Japan: Epidemiologic and pathologic studies. Jpn Circ J 1990; 54: 428-435.
12. Imano H, Kitamura A, Sato S, Kiyama M, Ohira T, Yamagishi K, et al. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: The Circulatory Risk in Communities Study (CIRCS). Stroke 2009; 40: 1571-1577.
13. Iso H, Imano H, Kitamura A, Sato S, Naito Y, Tanigawa T, et al. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 2004; 47: 2137-2144.
14. Yoshiike N, Matsumura Y, Iwaya M, Sugiyama M, Yamaguchi M. National Nutrition Survey in Japan. J Epidemiol 1996; 6: S189-S200.
15. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-five-year follow-up of the seven countries study. JAMA 1995; 274: 131-136.
16. Hirai Y, Geleijnse JM, Adachi H, Imaizumi T, Kromhout D. Systolic blood pressure predicts cardiovascular mortality in a farming but not in a fishing community: A 40-year follow-up of the Japanese cohorts of the seven countries study. Circ J 2011; 75: 1890-1896.
17. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: Report from the MIYAGI-AMI Registry Study. Circ J 2010; 74: 93-100.
18. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke 2003; 34: 2349-2354.
19. Okayama A, Ueshima H, Marmot M, Elliott P, Choudhury SR, Kita Y. Generational and regional differences in trends of mortality from ischemic heart disease in Japan from 1969 to 1992. Am J Epidemiol 2001; 153: 1191-1198.
20. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T, Yamashita T. Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol 2000; 29: 837-844.
21. Komachi Y, Tanaka H, Shimamoto T, Handa K, Iida M, Isomura K, et al. A collaborative study of stroke incidence in Japan: 1975-1979. Stroke 1984; 15: 28-36.
22. Konishi M, Komachi Y, Iso H, Iida M, Naito Y, Sato S, et al. Secular trends in atherosclerosis of coronary arteries and basal cerebral arteries in Japan: The Akita pathology study. Arteriosclerosis 1990; 10: 535-540.
23. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR Jr, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: The Akita Pathology Study. Stroke 1993; 24: 954-964.
24. Sankai T, Miyagaki T, Iso H, Shimamoto T, Iida M, Tanigaki M, et al. A population-based study of the proportion by type of stroke determined by computed tomography scan. Nihon Koshu Eisei Zasshi 1991; 38: 901-909 (in Japanese).
25. Turin TC, Kita Y, Rumana N, Nakamura Y, Takashima N, Ichikawa M, et al. Ischemic stroke subtypes in a Japanese population: Takashima Stroke Registry, 1988-2004. Stroke 2010; 41: 1871-1876.
26. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: The Northern Manhattan Study. Circulation 2005; 111: 1327-1331.
27. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR. Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities study. Stroke 2006; 37: 2493-2498.
28. Konishi M. Nihon-jin no jyunkanki shikkan no genten to sonogo no hensen (kouhen). Jpn Med J 2009; 4443: 53-59 (in Japanese).
29. Ueshima H. Explanation for the Japanese paradox: Prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-286.
30. Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol 2008; 167: 1358-1364.
31. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 1979; 59: 8-13.
32. Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996; 45(Suppl 3): S14-S16.
33. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
34. Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, et al. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population: NIPPON DATA80. Diabetologia 2008; 51: 575-582.
35. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: The Hisayama study. Stroke 2010; 41: 203-209.
36. Oizumi T, Daimon M, Jimbu Y, Wada K, Kameda W, Susa S, et al. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample: The Funagata study. Metabolism 2008; 57: 333-338.
37. Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, et al. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: The Suita Study. Hypertens Res 2010; 33: 1238-1243.
38. Saito I, Kokubo Y, Yamagishi K, Iso H, Inoue M, Tsugane S. Diabetes and the risk of coronary heart disease in the general Japanese population: The Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis 2011; 216: 187-191.
39. Cui R, Iso H, Yamagishi K, Saito I, Kokubo Y, Inoue M, et al. Diabetes mellitus and risk of stroke and its subtypes among Japanese: The Japan public health center study. Stroke 2011; 42: 2611-2614.
40. Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: The Japan public health centerbased study. Hypertens Res 2009; 32: 289-298.
41. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
42. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: A new worldwide definition: A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
43. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794-809 (in Japanese).
44. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
45. Gao W. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obes (Lond) 2008; 32: 757-762.
46. Saito I, Konishi M, Watanabe K, Kondo H, Fujimoto K, Okada K. The metabolic syndrome and risk of stroke in a rural community in Japan. Nippon Koshu Eisei Zasshi 2007; 54: 677-683 (in Japanese).
47. Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. Circ J 2009; 73: 878-884.
48. Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, et al. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: The Suita Study. Hypertens Res 2008; 31: 2027-2035.
49. Kadota A, Miura K, Okamura T, Hozawa A, Murakami Y, Fujiyoshi A, et al. Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: A 15-year follow-up of NIPPON DATA90. Atherosclerosis 2011; 215: 209-213.
50. Irie F, Iso H, Noda H, Sairenchi T, Otaka E, Yamagishi K, et al. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals: Ibaraki Prefectural Health Study. Circ J 2009; 73: 1635-1642.
51. Chei CL, Yamagishi K, Tanigawa T, Kitamura A, Imano H, Kiyama M, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among middle-aged Japanese. Hypertens Res 2008; 31: 1887-1894.
52. Examination Committee of Criteria for 'Obesity Disease' in Japan. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
53. Hata J, Doi Y, Ninomiya T, Tanizaki Y, Yonemoto K, Fukuhara M, et al. The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population. Atherosclerosis 2010; 210: 249-255.
54. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Nishimura K, et al. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: The Suita Study. Atherosclerosis 2011; 217: 201-206.
55. Saito I, Konishi M, Iso H, Inoue M, Tsugane S. Impact of weight change on specific-cause mortality among middle-aged Japanese individuals. J Epidemiol Community Health 2009; 63: 447-454.
56. Chei CL, Iso H, Yamagishi K, Inoue M, Tsugane S. Body mass index and weight change since 20 years of age and risk of coronary heart disease among Japanese: The Japan Public Health Center-Based Study. Int J Obes (Lond) 2008; 32: 144-151.
57. Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S. Body mass index, weight change and risk of stroke and stroke subtypes: The Japan Public Health Center-based prospective (JPHC) study. Int J Obes (Lond) 2011; 35: 283-291.
58. Yatsuya H, Toyoshima H, Yamagishi K, Tamakoshi K, Taguri M, Harada A, et al. Body mass index and risk of stroke and myocardial infarction in a relatively lean population: Meta-analysis of 16 Japanese cohorts using individual data. Circ Cardiovasc Qual Outcomes 2010; 3: 498-505.
59. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004; 35: 831-836.
60. Yonemoto K, Doi Y, Hata J, Ninomiya T, Fukuhara M, Ikeda F, et al. Body mass index and stroke incidence in a Japanese community: The Hisayama study. Hypertens Res 2011; 34: 274-279.
61. Park JW, Lee SY, Kim SY, Choe H, Jee SH. BMI and stroke risk in Korean women. Obesity (Silver Spring) 2008; 16: 396-401.
62. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
63. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
64. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214.
65. Nakamura M, Sato S, Shimamoto T. Establishment of external quality control program for hs-CRP and three-year follow-up of the performance for precision and accuracy. J Atheroscler Thromb 2007; 14: 287-293.
66. Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis 2007; 194: 238-244.
67. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004; 93: 1238-1242.
68. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46: 464-469.
69. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, et al. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011; 217: 187-193.
70. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28(Suppl): 615-640.
71. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-828.
72. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-1359.
73. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 1990; 82: 27-36.
74. Vaccaro O, Stamler J, Neaton JD. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol 1998; 27: 636-641.
75. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000; 133: 81-91.
76. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study. Lancet 1999; 353: 1649-1652.
77. Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G. Factor VIII and other hemostasis variables are related to incident diabetes in adults: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1999; 22: 767-772.
78. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
79. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-1108.
80. Stern MP. Diabetes and cardiovascular disease: The "common soil" hypothesis. Diabetes 1995; 44: 369-374.
81. Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Maeda K, et al. Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J 2011; 75: 2885-2892.